The role of nutraceutical proteins and peptides in apoptosis, angiogenesis, and metastasis of cancer cells

Cancer and Metastasis Reviews

Volumn 29, Issue 3, 2010, Pages 511-528

  De Mejia, Elvira Gonzalez ^a   Dia, Vermont P ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Angiogenesis; Apoptosis; Metastasis; Nutraceuticals; Peptides; Proteins

Indexed keywords

ANTINEOPLASTIC AGENT; APROTININ; BORTEZOMIB; BOWMAN BIRK INHIBITOR; BUCKWHEAT TRYPSIN INHIBITOR; CONCANAVALIN A; CYSTEINE PROTEINASE INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXORUBICIN; EPIDERMAL GROWTH FACTOR; FLICE INHIBITORY PROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTOFERRICIN; LACTOFERRIN; LUNASIN; NEUTROPHIL PEPTIDE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PLACENTAL GROWTH FACTOR; PLANT LECTIN; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; SHARK CARTILAGE PROTEIN; SURVIVIN; TALACTOFERRIN; TRANSFORMING GROWTH FACTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; VISCUM ALBUM LECTIN; VISCUMIN; X LINKED INHIBITOR OF APOPTOSIS;

ABRUS; ADVANCED CANCER; ALLERGIC REACTION; ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AUTOPHAGY; B CELL LYMPHOMA; BIOAVAILABILITY; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER PREVENTION; CANCER SURVIVAL; CANCER THERAPY; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL MEMBRANE PERMEABILITY; COLON CANCER; COLON CARCINOMA; COLORECTAL CANCER; CYTOTOXICITY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG TOLERABILITY; FATIGUE; GASTROINTESTINAL TOXICITY; HUMAN; KIDNEY CARCINOMA; LEUKEMIA CELL; LEUKEMIA CELL LINE; LEUKOPLAKIA; LEWIS CARCINOMA; LIVER CELL CARCINOMA; LOW DRUG DOSE; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LYMPHATIC LEUKEMIA; LYMPHOMA CELL; MELANOMA; METASTASIS; MOUTH CARCINOMA; MULTIPLE MYELOMA; MYELOID LEUKEMIA; NAUSEA; NONHUMAN; OSTEOSARCOMA; OVARY CANCER; OVERALL SURVIVAL; PERITONEUM METASTASIS; PHASEOLUS VULGARIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CARCINOMA; RECOMMENDED DRUG DOSE; REVIEW; SKIN CANCER; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; TUMOR CELL; TUMOR XENOGRAFT; UNSPECIFIED SIDE EFFECT; UPREGULATION; UTERINE CERVIX CARCINOMA; VISCUM ALBUM; VOMITING;

ANIMALS; APOPTOSIS; DIETARY SUPPLEMENTS; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE FRAGMENTS; PROTEINS;

EID: 77957604071     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10555-010-9241-4     Document Type: Review

References (174)

1. GP Zaloga RA Siddiqui 2004 Biologically active dietary peptides Mini-Reviews in Medicinal Chemistry 4 815 821 1:CAS:528:DC%2BD2cXns1SktbY%3D 15544542
2. CA Haller 2010 Nutraceuticals: has there been any progress? Clinical Pharmacology and Therapeutics 87 137 141 1:STN:280:DC%2BC3c%2FmtFymsA%3D%3D 20107443 10.1038/clpt.2009.250
3. EK Lakra 2003 Nutraceutical-definition and introduction AAPS PharmSci 5 1 2
4. GK Grimble 1994 The significance of peptides in clinical nutrition Annual Review of Nutrition 14 419 447 1:CAS:528:DyaK2cXmtVeqsLg%3D 7946528 10.1146/annurev.nu.14.070194.002223
5. A Jemal R Siegel E Ward YP Hao JQ Xu MJ Thun 2009 Cancer statistics, 2009 CA: A Cancer Journal for Clinicians 59 225 249 10.3322/caac.20006
6. FL Greene AK Stewart HJ Norton 2002 A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50,042 patients Annals of Surgery 236 416 421 12368669 10.1097/00000658-200210000-00003
7. JB O'Connell MA Maggard CY Ko 2004 Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging Journal of the National Cancer Institute 96 1420 1425 15467030 10.1093/jnci/djh275 (Pubitemid 39429665)
8. JA Meyerhardt RJ Mayer 2005 Systemic therapy for colorectal cancer The New England Journal of Medicine 352 476 487 1:CAS:528:DC%2BD2MXptlWkuw%3D%3D 15689586 10.1056/NEJMra040958 (Pubitemid 40175974)
9. NJ West EDJ Courtney AP Poullis RJ Leicester 2009 Apoptosis in the colonic crypt, colorectal adenomata and manipulation by chemoprevention Cancer Epidemiology, Biomarkers & Prevention 18 1680 1687 1:CAS:528: DC%2BD1MXmvF2jsr8%3D 10.1158/1055-9965.EPI-09-0006
10. AH Wyllie GJ Beattie AD Hargreaves 1981 Chromatin changes in apoptosis The Histochemical Journal 13 681 692 1:STN:280:DyaL38%2FnsFChsQ%3D%3D 6975767 10.1007/BF01002719 (Pubitemid 11014660)
11. AH Wyllie 1980 Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation Nature 284 555 556 1:CAS:528: DyaL3cXktlOrur4%3D 6245367 10.1038/284555a0
12. H Okada TW Mak 2004 Pathways of apoptotic and non-apoptotic death in tumor cells Nature Reviews. Cancer 4 592 603 1:CAS:528:DC%2BD2cXmtVOhsb8%3D 15286739 10.1038/nrc1412
13. KM Debatin PH Krammer 2004 Death receptors in chemotherapy and cancer Oncogene 23 2950 2966 1:CAS:528:DC%2BD2cXivFKmsbw%3D 15077156 10.1038/sj.onc.1207558 (Pubitemid 38638855)
14. D Hanahan RA Weeinberg 2000 The hallmarks of cancer Cell 100 57 70 1:CAS:528:DC%2BD3cXks1CktA%3D%3D 10647931 10.1016/S0092-8674(00)81683-9
15. N Murukesh C Dive GC Jayson 2010 Biomarkers of angiogenesis and their roles in the development of VEGF inhibitors British Journal of Cancer 102 8 18 1:CAS:528:DC%2BC3cXhtFOltA%3D%3D 20010945 10.1038/sj.bjc.6605483
16. S Boehm C Rothermundt D Hess M Joerger 2010 Antiangiogenic drugs in oncology: a focus on drug safety and the elderly-a mini-review Gerontology 56 303 309 1:CAS:528:DC%2BC3cXlsVOgtLc%3D 19940466 10.1159/000262450
17. T Winder HJ Lenz 2010 Vascular endothelial growth factor and epidermal growth factor signaling pathways as therapeutic targets for colorectal cancer Gastroenterology 138 2163 2176 1:CAS:528:DC%2BC3cXms1yiur4%3D 20420953 10.1053/j.gastro.2010.02.005
18. G Korpanty E Smyth LA Sullivan RA Brekken D Carney 2010 Antiangiogenic therapy in lung cancer: focus on vascular endothelial growth factor pathway Experimental Biology and Medicine 235 3 9 1:CAS:528:DC%2BC3cXjsFaqu7s%3D 20404013 10.1258/ebm.2009.009191
19. AH Tan N Xia F Gao ZN Mo YF Cao 2010 Angiogenesis-inhibitors for metastatic thyroid cancer Cochrane Database of Systematic Reviews 3 CD007958
20. J Westermarck VM Kahari 1999 Regulation of matrix metalloproteinase expression in turner invasion The FASEB Journal 13 781 792 1:CAS:528: DyaK1MXjtFGksrs%3D 10224222
21. JN Losso 2008 The biochemical and functional food properties of the Bowman-Birk inhibitor Critical Reviews in Food Science and Nutrition 48 94 118 1:CAS:528:DC%2BD1cXhvFWhs7c%3D 18274967 10.1080/10408390601177589 (Pubitemid 351261525)
22. A Clemente C Domoney 2006 Biological significance of polymorphism in legume protease inhibitors from the Bowman-Birk family Current Protein & Peptide Science 7 201 216 1:CAS:528:DC%2BD28Xmt1emtLY%3D 10.2174/ 138920306777452349 (Pubitemid 43881003)
23. FL Meykens 2001 Development of Bowman-Birk inhibitor for chemoprevention of oral head and neck cancer. Cancer prevention-molecular mechanisms to clinical applications Annals of the New York Academy of Sciences 952 116 123 10.1111/j.1749-6632.2001.tb02732.x
24. T Saito H Sato N Virgona H Hagiwara K Kashiwagi K Suzuki, et al. 2007 Negative growth control of osteosarcoma cell by Bowman-Birk protease inhibitor from soybean; involvement of connexin 43 Cancer Letters 253 249 257 1:CAS:528:DC%2BD2sXnsFKqsL0%3D 17343982 10.1016/j.canlet.2007.01.021 (Pubitemid 47017537)
25. K Suzuki T Yano Y Sadzuka T Sugiyama T Seki R Asano 2005 Restoration of connexin 43 by Bowman-Birk protease inhibitor in M5076 bearing mice Oncology Reports 13 1247 1250 1:CAS:528:DC%2BD2MXltV2ksb0%3D 15870950
26. YW Chen SC Huang SY Lin-Shiau JK Lin 2005 Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1 Carcinogenesis 26 1296 1306 1:CAS:528:DC%2BD2MXmsVegsLw%3D 15746161 10.1093/carcin/bgi062 (Pubitemid 41417909)
27. X Du K Beloussow WC Shei 2001 Bowman-Birk protease inhibitor and tis palmitic acid conjugate prevent 7,12-dimethylbenz[a]anthracene-induced transformatiob in cultured mouse mammary glands Cancer Letters 164 135 141 1:CAS:528:DC%2BD3MXhtFSltL4%3D 11179827 10.1016/S0304-3835(01)00381-0 (Pubitemid 32155500)
28. L Honeycutt J Wang H Whrami WC Shen 1996 Comparison of pharmacokinetic parameters of a polypeptide, the Bowman-Birk protease inhibitor (BBI) and its palmitic acid conjugate Pharmaceutical Research 13 1373 1377 1:CAS:528:DyaK28XmtFWltbw%3D 8893277 10.1023/A:1016078118033 (Pubitemid 26344984)
29. GA Joanitti RB Azevedo SM Freitas 2010 Apoptosis and lysosome membrane permeabilization induction on breast cancer cells by an anticarcinogenic Bowman-Birk protease inhibitor from Vigna unguiculata seeds Cancer Letters 293 73 81 1:CAS:528:DC%2BC3cXlsVyit74%3D 20133052 10.1016/j.canlet.2009.12.017
30. AR Kennedy XS Wan 2002 Effects of the Bowman-Birk inhibitor on growth, invasion, and clonogenic survival of human prostate epithelial cells and prostate cancer cells The Prostate 50 125 133 1:CAS:528:DC%2BD38XhsFSht7Y%3D 11816021 10.1002/pros.10041 (Pubitemid 34123702)
31. MX Tang M Asamoto K Ogawa A Naiki-Ito S Sato S Takahashi, et al. 2009 Induction of apoptosis in the LNCap human prostate carcinoma cell line and prostate adenocarcinomas of SV40T antigen transgenic rats by the Bowman-Birk inhibitor Pathology International 59 790 796 1:CAS:528:DC%2BD1MXhs1Wju7nL 19883429 10.1111/j.1440-1827.2009.02445.x
32. AR Kennedy PC Billings XS Wan PM Newberne 2002 Effects of Bowman-Birk inhibitor on rat colon carcinogenesis Nutrition and Cancer 43 174 186 1:CAS:528:DC%2BD3sXhtV2ls7k%3D 12588698 10.1207/S15327914NC4328
33. P Caccialupi LR Ceci RA Siciliano D Pignone A Clemente G Sonnante 2010 Bowman-Birk inhibitors in lentil: heterologous expression, functional characterization and anti-proliferative properties in human colon cancer cells Food Chemistry 120 1058 1066 1:CAS:528:DC%2BC3cXht1Krtb8%3D 10.1016/j.foodchem. 2009.11.051
34. A Clemente JM Gee IT Johnson DA MacKenzie C Domoney 2005 Pea (Pisum sativum L.) protease inhibitors from the Bowman-Birk class influence the growth of human colorectal adenocarcinoma HT29 cells in vitro Journal of Agricultural and Food Chemistry 53 8979 8986 1:CAS:528:DC%2BD2MXhtFegs7%2FL 16277391 10.1021/jf051528w (Pubitemid 41735661)
35. A Clemente FJ Moreno MCD Marin-Manzano E Jimenez C Domoney 2010 The cytotoxic effect of Bowman-Birk isoinhibitors, IBB1 and IBBD2, from soybean (Glycine max) on HT29 human colorectal cancer cells is related to their intrinsic ability to inhibit serine proteases Molecular Nutrition & Food Research 54 396 405 1:CAS:528:DC%2BC3cXjtFKhs7s%3D 10.1002/mnfr.200900122
36. WB Armstrong XS Wan AR Kennedy TH Taylor FL Meyskens 2003 Development of the Bowmn-Birk inhibitor for oral cancer chemoprevention and analysis of neu immunohistochemical staining intensity with Bowman-Birk inhibitor concentrate treatment The Laryngoscope 113 1687 1702 1:CAS:528:DC%2BD3sXns12qu7k%3D 14520092 10.1097/00005537-200310000-00007 (Pubitemid 37210969)
37. WB Armstrong AR Kennedy XS Wan TH Taylor QA Nguyen J Jensen, et al. 2000 Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a Phase IIa chemoprevention trial Clinical Cancer Research 6 4684 4691 1:CAS:528:DC%2BD3MXotlemsA%3D%3D 11156220
38. AR Kennedy D Kritchevsky WC Shen 2003 Effects of spermine-conjugated Bowman-Birk inhibitor (spermine-BBI) on carcinogenesis and cholesterol biosynthesis in mice Pharmaceutical Research 20 1908 1910 1:CAS:528: DC%2BD3sXpvVShsLo%3D 14725352 10.1023/B:PHAM.0000008035.02046.cb (Pubitemid 38005519)
39. H Witschi I Espiritu 2002 Development of tobacco-smoke-induced lung tumors in mice fed Bowman-Birk protease inhibitor concentrate Cancer Letters 183 141 146 1:CAS:528:DC%2BD38XksValsLY%3D 12065088 10.1016/S0304-3835(02)00156-8 (Pubitemid 34628417)
40. H Kobayashi Y Fukuda R Yoshida Y Kanada S Nishiyama M Suzuki 2004 Suppressing effects of dietary supplementation of soybean trypsin inhibitor on spontaneous, experimental and peritoneal disseminated metastasis in mouse model International Journal of Cancer 112 519 524 1:CAS:528:DC%2BD2cXovVelsLw%3D 10.1002/ijc.20430 (Pubitemid 39390619)
41. M Kunitz 1945 Cystallization of a trypsin inhibitor from soybean Science 101 668 669 1:CAS:528:DyaH2MXitlOltA%3D%3D 17777539 10.1126/science.101.2635.668
42. H Kobayashi M Suzuki N Kanayama T Terao 2004 A soybean Kunitz trypsin inhibitor suppresses ovarian cancer cell invasion by blocking urokinase upregulation Clinical & Experimental Metastasis 21 159 166 1:CAS:528:DC%2BD2cXjt1Clu7Y%3D 10.1023/B:CLIN.0000024751.73174.c2
43. K Inagaki H Kobayashi R Yoshida Y Kanada Y Fukuda T Yagyu, et al. 2005 Suppression of urokinase expression and invasion by a soybean Kunitz trypsin inhibitor are mediated through inhibition of src-dependent signaling pathways The Journal of Biological Chemistry 280 31428 31437 1:CAS:528: DC%2BD2MXpslaqur8%3D 16002410 10.1074/jbc.M501406200 (Pubitemid 41291884)
44. EF Fang JH Wong TB Ng 2010 Thermostable Kunitz trypsin inhibitor with cytokine inducing, antitumor and HIV-1 reverse transcriptase activities from Korean large black soybeans Journal of Bioscience and Bioengineering 109 211 217 1:CAS:528:DC%2BC3cXmtleisLo%3D 20159565 10.1016/j.jbiosc.2009.08.483
45. SS Park H Ohba 2004 Suppressive activity of protease inhibitors from buckwheat seeds against human T-acute lymphoblastic leukemia cell lines Applied Biochemistry and Biotechnology 117 65 74 1:CAS:528:DC%2BD2cXks12ltbw%3D 15159551 10.1385/ABAB:117:2:065
46. Z Zhang Y Li C Li J Yuan Z Wang 2007 Expression of a buckwheat trypsin inhibitor gene in Escherichia coli and its effect on multiple myeloma IM-9 cell proliferation Acta Biochimica et Biophysica Sinica 39 701 707 1:CAS:528:DC%2BD2sXhtF2hsbzJ 17805465 10.1111/j.1745-7270.2007.00332.x (Pubitemid 47437947)
47. ZH Wang L Gao YY Li Z Zhang JM Yuan HW Wang, et al. 2007 Induction of apoptosis by buckwheat trypsin inhibitor in chronic myeloid leukemia K562 cells Biological & Pharmaceutical Bulletin 30 783 786 1:CAS:528: DC%2BD2sXls1akurw%3D 10.1248/bpb.30.783 (Pubitemid 46570974)
48. YY Li Z Zhang ZH Wang HW Wang L Zhang L Zhu 2009 rBTI induces apoptosis in human solid tumor cell lines by loss in mitochondrial transmembrane potential and caspase activation Toxicology Letters 189 166 175 1:CAS:528: DC%2BD1MXotFyrs7g%3D 19481592 10.1016/j.toxlet.2009.05.018
49. MF Troncoso PC Zolezzi U Hellman C Wolfenstein-Todel 2003 A novel trypsin inhibitor from Peltophorum dubium seeds, with lectin-like properties, triggers rat lymphoma apoptosis Archives of Biochemistry and Biophysics 411 93 104 10.1016/S0003-9861(02)00726-9 (Pubitemid 36268783)
50. GH Huang MJ Sheu HJ Chen YS Chang YH Lin 2007 Growth inhibition and induction of apoptosis in NB4 promyelocytic leukemia cells by trypsin inhibitor from sweet potato storage roots Journal of Agricultural and Food Chemistry 55 2548 2553 1:CAS:528:DC%2BD2sXit1entLc%3D 17328557 10.1021/jf063008m (Pubitemid 46623748)
51. N Severe M Filipic J Brzin TT Lah 2002 Effect of cysteinse proteinase inhibitors on murine B16 melanoma cell invasion in vitro Biological Chemistry 383 839 842 10.1515/BC.2002.088 (Pubitemid 34649903)
52. C Blanco-Aparicio MA Molina E Fernandez-Salas ML Frazier JM Mas E Querol, et al. 1998 Potato carboxypeptidase inhibitor, a T-knot protein, is an epidermal growth factor antagonist that inhibits tumor cell growth The Journal of Biological Chemistry 273 12370 12377 1:CAS:528:DyaK1cXjtlSgtLg%3D 9575190 10.1074/jbc.273.20.12370 (Pubitemid 28240606)
53. M Sitja-Arnau MA Molina C Blano-Aparicio L Ferrer-Soler J Lorenzo FX Aviles, et al. 2005 Mechanism of action of potato carboxypeptidase inhibitor (PCI) as an EGF blocker Cancer Letters 226 169 184 1:CAS:528: DC%2BD2MXmsVaitr0%3D 16039955 10.1016/j.canlet.2005.01.025 (Pubitemid 41039085)
54. K Ashida H Sazaki YA Suzuki B Lonnerdal 2004 Cellular internalization of lactoferrin in intestinal epithelial cells Biometals 17 311 315 1:CAS:528:DC%2BD2cXjvFartbY%3D 15222483 10.1023/B:BIOM.0000027710.13543.3f (Pubitemid 38987155)
55. YA Suzuki B Lopez B Lonnerdal 2005 Mammalian lactoferrin receptors: structure and function Cellular and Molecular Life Sciences 62 2560 2575 1:CAS:528:DC%2BD2MXhtlSms7vN 16261254 10.1007/s00018-005-5371-1 (Pubitemid 41721230)
56. KA Son J Park CK Chung DK Chung DY Yu KK Lee, et al. 2002 Human lactoferrin activates transcription of IL-1 beta gene in mammalian cells Biochemical and Biophysical Research Communications 290 236 241 1:CAS:528:DC%2BD38XhsFChtQ%3D%3D 11779159 10.1006/bbrc.2001.6181 (Pubitemid 34694489)
57. B Lonneral 2009 Nutritional roles of lactoferrin Current Opinion in Clinical Nutrition and Metabolic Care 12 293 297 10.1097/MCO.0b013e328328d13e 1:CAS:528:DC%2BD1MXktl2jsrY%3D
58. JK Actor SA Hwang ML Kruzel 2009 Lactoferrin as a natural immune modulator Current Pharmaceutical Design 15 1956 1973 1:CAS:528: DC%2BD1MXotFKht7k%3D 19519436 10.2174/138161209788453202
59. SA Gonzalez-Chavez S Arevalo-Gallegos Q RAscon-Cruz 2009 Lactoferrin: structure, function and applications International Journal of Antimicrobial Agents 33 301 306 18842395 10.1016/j.ijantimicag.2008.07.020 1:CAS:528:DC%2BD1MXivVKgs7s%3D
60. B Lonnerdal S Iyer 1995 Lactoferrin-molecular structure and biological function Annual Review of Nutrition 15 93 110 1:CAS:528:DyaK2MXntVCjsrw%3D 8527233 10.1146/annurev.nu.15.070195.000521
61. L Rodirgues J Teixera S Fernando M Paulsson HL Mansson 2009 Lactoferin and cancer disease prevention Critical Reviews in Food Science and Nutrition 49 203 217 10.1080/10408390701856157 1:CAS:528:DC%2BD1cXhsFWmsbnF
62. E Damiens IE Yazidi J Mazurier I Duthille G Spik Y Boily-Marer 1999 Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells Journal of Cellular Biochemistry 74 486 498
63. Y Xiao CL Monitto KM Minhas D Sidransky 2004 Lactoferrin down-regulates G1 cyclin-dependent kinases during growth arrest of head and neck cancer cells Clinical Cancer Research 10 8683 8686 1:CAS:528:DC%2BD2cXhtFGjsL%2FO 15623653 10.1158/1078-0432.CCR-04-0988 (Pubitemid 40053437)
64. HJ Son SH Lee SY Choi 2006 Human lactoferrin controls the level of retinoblastoma protein and its activity Biochemistry and Cell Biology 84 345 350 1:CAS:528:DC%2BD28Xpt1Smsbw%3D 16936805 10.1139/O06-048 (Pubitemid 44341309)
65. JS Wolf G Li A Varadhachary K Petark M Schneyer D Li J Ongkasuwan, et al. 2007 Oral lactoferrin results in T cell-dependent tumor inhibition of head and neck squamous cell carcinoma in vivo Clinical Cancer Research 13 1601 1610 1:CAS:528:DC%2BD2sXitlSjtLc%3D 17332307 10.1158/1078-0432.CCR-06-2008 (Pubitemid 46450453)
66. KVPC Mohan R Kumaragupuran D Prathiba S Nagini 2006 Modulation of xenobiotic-metabolizing enzymes and redox status during chemoprevention of hamster buccal carcinogenesis by bovine lactoferrin Nutrition 22 940 946 1:CAS:528:DC%2BD28XosVOgsLY%3D 10.1016/j.nut.2006.05.017 (Pubitemid 44234018)
67. Y Matsuda K Saoo K Hosokawa K Yamakawa M Yokohira Y Zeng, et al. 2007 Post-initiation chemopreventive effects of dietary bovine lactoferrin on 4-(methynitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in female A/J mice Cancer Letters 246 41 46 1:CAS:528:DC%2BD2sXpvFen 16530328 10.1016/j.canlet.2006.01.034 (Pubitemid 44959376)
68. N Zemann P Klein E Wetzel F Huettinger M Huettinger 2010 Lactoferrin induces growth arrest and nuclear accumulation of Smad-2 in Hela cells Biochimie 92 880 884 1:CAS:528:DC%2BC3cXntFSgsrY%3D 20347004 10.1016/j.biochi.2010.03.013
69. K Norrby I Mattsby-Baltzer M Innocenti S Tuneberg 2001 Orally administered bovine lactoferrin systemically inhibits VEGF165-mediated angiogenesis in the rat International Journal of Cancer 91 236 240 1:CAS:528:DC%2BD3MXot1Kisg%3D%3D 10.1002/1097-0215(200002)9999:9999<::AID- IJC1024>3.3.CO;2-K
70. M Shimamura Y Yamamoto H Ashino T Oikawa T Hazato H Tsuda, et al. 2004 Bovine lactoferrin inhibits tumor-induced angiogenesis International Journal of Cancer 111 111 116 1:CAS:528:DC%2BD2cXlsFWrtbw%3D 10.1002/ijc.20187 (Pubitemid 38859291)
71. K Tsuda K Sekine N Takasuka H Toriyama-Baba M Iigo 2000 Prevention of colon carcinogenesis and carcinoma metastasis by orally administered bovine lactoferrin in animals Biofactors 12 83 88 1:CAS:528:DC%2BD3MXhsFegtbk%3D 11216510 10.1002/biof.5520120113
72. T Kuhara M Iigo T Itoh Y Ushida K Sekine N Terada, et al. 2000 Orally administered lactoferrin exerts an antimetastatic effect and enhances production of IL-18 in the intestinal epithelium Nutrition and Cancer 38 192 199 1:CAS:528:DC%2BD3MXmsF2hs7g%3D 11525597 10.1207/S15327914NC382-8
73. M Iigo M Shimamura E Matsuda K Fujita H Nomoto J Satoh, et al. 2004 Orally administered bovine lactoferrin induces casapse-1 and interleukin-18 in the mouse intestinal mucosa: a possible explanation for inhibition of carcinogenesis and metastasis Cytokine 25 36 44 1:CAS:528:DC%2BD3sXpvVWlsrg%3D 14687584 10.1016/j.cyto.2003.09.009 (Pubitemid 37543696)
74. K Sakamoto Y Ito T Mori K Sugimura 2006 Interaction of human lactoferrin with cell adhesion molecules through RGD motif elucidated by lactoferrin-binding epitopes The Journal of Biological Chemistry 281 24472 24478 1:CAS:528:DC%2BD28Xot1eqsbc%3D 16787913 10.1074/jbc.M604974200 (Pubitemid 44274221)
75. STW McKeown FT Lundy J Nelson D Lockhart CR Irwin CG Cowan, et al. 2006 The cytotoxic effect s of human neutrophil peptides-1 (HNP1) and lactoferrin on oral squamous cell carcinoma (OSCC) in vitro Oral Oncology 42 685 690 1:CAS:528:DC%2BD28XntlGiuro%3D 16483834 10.1016/j.oraloncology.2005.11.005 (Pubitemid 44094234)
76. KV Mohan P Gunasekaran E Varalakshmi Y Hara S Nagini 2007 In vitro evaluation of the anticancer effect of lactoferrin and tea polyphenol combination on oral carcinoma cells Cell Biology International 31 599 608 1:CAS:528:DC%2BD2sXkvFGrtbw%3D 17258915 10.1016/j.cellbi.2006.11.034 (Pubitemid 46661989)
77. PV Letchoumy KV Mohan JJ Stegeman HV Gelboin Y Hara S Nagini 2008 In vitro antioxidative potential of lactoferrin and black tea polyphenols and protective effects in vivo on carcinogen activation, DNA damage, proliferation, invasion, and angiogenesis during experimental oral carcinogenesis Oncology Research 2008 17 193 203 10.3727/096504008786111365
78. KVPC Mohan PV Letchoumy Y Hara S Nagini 2008 Combination chemoprevention of hamster buccal pouch carcinogenesis by bovine milk lactoferrin and black tea polyphenols Cancer Investigation 26 193 201 1:CAS:528:DC%2BD1cXhs1Wnsr0%3D 18259952 10.1080/07357900701511961 (Pubitemid 351225464)
79. R Haba S Watanabe W Masahiro S Udaka 2004 Effects of lactoferrin, soya germ and polyamine on 2-amino-1methyl-6-phenylimidazo[4,5-b]-pyridine(PhIP)- induced breast carcinogenesis in rats Biofactors 22 127 131 1:CAS:528: DC%2BD2cXhtFGns7nJ 15630267 10.1002/biof.5520220125
80. PP Ward E Paz OM Conneely 2005 Multifunctional roles of lactoferrin: a critical overview Cellular and Molecular Life Sciences 22 2540 2548 10.1007/s00018-005-5369-8 1:CAS:528:DC%2BD2MXhtlSms7rF (Pubitemid 41721229)
81. D McBride 2007 Talactoferrin alpha receives fast-track designation for the treatment of non-small cell lung cancer ONS Connect 22 14 17393636
82. Y Wang D Raghunadharao G Raman D Doval S Advani P Julka, et al. 2006 Adding oral talactoferrin to first-line NSCLC chemotherapy safely enhanced efficacy in a randomized trial Journal of Clinical Oncology 24 187
83. TG Hayes GF Faclchook GR Varadhachary DP Smith LD Davis HM Dhingra, et al. 2006 Phase I trial of oral talactoferrin alfa in refractory solid tumors Investigational New Drugs 24 233 240 1:CAS:528:DC%2BD28XktlWls7Y%3D 16193240 10.1007/s10637-005-3690-6 (Pubitemid 43723899)
84. TG Hayes GS Falchook A Varadhachary 2010 Phase IB trial of oral talactoferrin in the treatment of patients with metastatic solid tumors Investigational New Drugs 28 156 162 1:CAS:528:DC%2BC3cXis1ygu7k%3D 19238327 10.1007/s10637-009-9233-9
85. E Jonasch WM Stadler RM Bukowski TG Hayes A Varadhachary R Malik, et al. 2008 Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma Cancer 113 72 77 1:CAS:528:DC%2BD1cXos1yhsbY%3D 18484647 10.1002/cncr.23519 (Pubitemid 351976388)
86. w Bellamy M Takase H Wakabayashi K Kawase M Tomita 1992 Antibacterial spectrum of lactoferricin-B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin The Journal of Applied Bacteriology 73 472 479 1:CAS:528:DyaK3sXkt1Cnt7g%3D 1490908
87. T Sakai Y Banno Y Kato Y Nozawa M Kawaguchi 2005 Pepsin-digested lactoferrin induces apoptotic cell death with JNK/SAPK activation in oral cancer cells Journal of Pharmacological Sciences 98 41 48 1:CAS:528: DC%2BD2MXksFGqu7s%3D 15879678 10.1254/jphs.FPJ04047X (Pubitemid 40806126)
88. SJ Mader J Salsman DM Conrad DW Hoskin 2005 Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines Molecular Cancer Therapeutics 4 612 624 1:CAS:528:DC%2BD2MXjtFegsLw%3D 15827335 10.1158/1535-7163.MCT-04-0077 (Pubitemid 40601843)
89. LT Eliassen G Berge A Leknessund M Wikman I Lindin C Lokke, et al. 2006 The antimicrobial peptide, Lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo International Journal of Cancer 119 493 500 1:CAS:528:DC%2BD28Xmtlyjsr8%3D 10.1002/ijc.21886 (Pubitemid 43955700)
90. C Freiburgahus B Janicke H Lindmark-Mansson SM Oredsson MA Paulsson 2009 Lactoferricin treatment decreases the rate of cell proliferation of a human colon cancer cell line Journal of Dairy Science 92 247 2484 10.3168/jds.2008- 1386 1:CAS:528:DC%2BD1MXlsVyjtA%3D%3D
91. A Richardosn R de Antueno R Duncan DW Hoskin 2009 Intracellular delivery of bovine lactoferricin's antimicrobial core (RRWQWR) kills T-leukemia cells Biochemical and Biophysical Research Communications 388 736 741 10.1016/j.bbrc.2009.08.083 1:CAS:528:DC%2BD1MXhtFajsbzP
92. G Berge LT Eliassen KA Camilio K Bartnes B Sveinbjornsson O Rekdal 2010 Therapeutic vaccination against a murine lymphoma by intratumoral injection of a cationic anticancer peptide Cancer Immunology, Immunotherapy 59 1285 1294 10.1007/s00262-010-0857-6 1:CAS:528:DC%2BC3cXmsFyku7g%3D 20422410 10.1007/s00262-010-0857-6
93. YC Yoo S Watanabe R Wataanbe K Hata K Shimazaki I Azuma 1997 Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice Japanese Journal of Cancer 88 184 190 1:CAS:528:DyaK2sXhs1Krsr4%3D
94. S Mader D Smyth J Marshall DW Hoskin 2006 Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells The American Journal of Pathology 169 1753 1766 1:CAS:528:DC%2BD28Xht12isrzF 17071598 10.2353/ajpath.2006.051229 (Pubitemid 351182006)
95. E Dupont P Falardeu SA Mousa V Dimitriadou MC Pepin T Wang, et al. 2002 Antiangiogenic and antimetastatic properties of Neovastat (AE-941), an orally active extract derived from cartilage tissue Clinical & Experimental Metastasis 19 145 153 1:CAS:528:DC%2BD38XjtlCitLo%3D 10.1023/A:1014546909573 (Pubitemid 34264084)
96. JR Sheu CC Fu ML tsai WJ Chung 1998 Effect of U-995, a potent shark cartilage-derived angiogenesis inhibitor, on anti-angiogenesis and anti-tumor activities Anticancer Research 18 4435 4441 1:CAS:528:DyaK1MXmvVahug%3D%3D 9891506
97. + tumor infiltrating lymphocytes by a fractions isolated from shark cartilage: shark cartilage modulates anti-tumor immunity International Immunopharmacology 3 921 926 1:CAS:528: DC%2BD3sXks1antLs%3D 12810349 10.1016/S1567-5769(02)00255-2 (Pubitemid 36694862)
98. ZM Hassan R Feyzi A Sheikhian A Bargahi A Mostafaie K Mansouri, et al. 2005 Low molecular weight fraction of shark cartilage can modulate immune responses and abolish angiogenesis International Immunopharmacology 5 961 970 1:CAS:528:DC%2BD2MXjtF2htL4%3D 15829412 10.1016/j.intimp.2005.01.006
99. JS Chen CM Chang JC Wu SM Wang 2000 Shark cartilage extract interferes with cell adhesion aqnd induces reorganization of focal adhesions in cultured endothelial cells Journal of Cellular Biochemistry 78 417 428
100. F Zeng TX Xie WX Yang ZX Zhang JX yu Y Pang 2001 A preliminary study of purification and bioactivity of a 12,000 shark cartilage angiogenesis inhibitor Chemical Journal of Chinese Universities 2 1462 1465
101. XR Shen DM Ji YQ hu FX jia L Wang ZY Chu, et al. 2001 SCAIF80, a novel inhibitor of angiogenesis, and its effect on tumor growth Acta Biochimica et Biophysica Sinica 33 99 104 1:CAS:528:DC%2BD3MXhvFWjsL8%3D 12053197
102. F Zeng WX Yang KY Cui W Liu ZX Zhang JX Yu, et al. 2003 Studies on purification and bioactivity of 17,400 shark cartilage angiogenesis inhibitor Chemical Journal of Chinese Universities 24 1588 1591 1:CAS:528: DC%2BD3sXosFKktLc%3D
103. H Luo J Xu X yu 2007 Isolation and bioactivity of an angiogenesis inhibitor extracted from the cartilage of Dastayis akajei Asia Pacific Journal of Clinical Nutrition 16 286 289 1:CAS:528:DC%2BD2sXntVyltrw%3D 17392120
104. BE Kern JH Balcom BA Antoniu AL Warshaw C Fernandez-del Castillo 2003 Troponin I peptide (Glu94-Leu123), a cartilage-derived angiogenesis inhibitor: in vitro and in vivo effects on human endothelial cells and pancreatic cancer Journal of Gastrointestinal Surgery 7 961 969 14675705 10.1016/j.gassur.2003.08. 003 (Pubitemid 37524063)
105. RM Bukowski 2003 AE-941, a multifunctional antiangiogenic compound: trials in renal cell carcinoma Expert Opinion on Investigational Drugs 12 1403 1411 1:CAS:528:DC%2BD3sXlslShsLw%3D 12882625 10.1517/13543784.12.8.1403 (Pubitemid 36949697)
106. R Barber B Delahun SKG Grebe PF Davis A Thornton GC Slim 2001 Oral shark cartilage does not abolish carcinogenesis but delays tumor progression in a murine model Anticancer Research 21 1065 1069 1:STN:280:DC%2BD3MzivVOluw%3D%3D 11396141
107. MR Horsman J Alsner J Overgaard 1998 The effect of shark cartilage extracts on the growth and metastatic spread of the SCCVII carcinoma Acta Oncologica 37 441 445 1:STN:280:DyaK1M%2FkslaltQ%3D%3D 9831372 10.1080/028418698430386 (Pubitemid 28505985)
108. DR Miller GT Anderson JJ Stark JL Granick D Richardson 1998 Phase I/II trial of the safety and efficacy of shark cartilage in the treatment of advanced cancer Journal of Clinical Oncology 16 3649 3655 1:STN:280: DyaK1M%2Fjt1Wquw%3D%3D 9817287
109. CL Loprinzi R Levitt BL Barton JA Sloan PJ Atherton DJ Smith, et al. 2005 Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group Trial Cancer 104 176 182 15912493 10.1002/cncr.21107 (Pubitemid 40847766)
110. L Zheng P Ling Z Wang R Niu C Hu T Zhang, et al. 2007 A novel polypeptide from shark cartilage with potent anti-angiogenic activity Cancer Biology & Therapy 6 775 780 1:CAS:528:DC%2BD2sXhtVyrsrjE 10.4161/cbt.6.5.4002
111. A Abbani-Chadegani S Abdossamadi A Bargahi M Yousef-Masboogh 2008 Identification of low-molecular weight protein (SCP1) from shark cartilage with anti-angiogenesis activity and sequence similarity to parvalbumin Journal of Pharmaceutical and Biomedical Analysis 46 563 567 10.1016/j.jpba.2007.10.029 1:CAS:528:DC%2BD1cXlvV2nsQ%3D%3D
112. I Murota T Tamai T Baba R Sato K Hashimoto EY Park Y Nakamura, et al. 2010 Uric acid lowering effect by ingestion of proteolytic digest of shark cartilage and its basic fraction Journal of Food Biochemistry 34 182 194 1:CAS:528:DC%2BC3cXjs1GqsLY%3D 10.1111/j.1745-4514.2009.00273.x
113. N Sharon 2008 Lectins: past, present, and future Biochemical Society Transactions 36 1457 1460 1:CAS:528:DC%2BD1cXhsVCgsbrO 19021575 10.1042/BST0361457
114. EJM Van Damme WJ Peumans A Barre P Rouge 1998 Plant lectins: a composite of several distinct families of structurally related and evolutionary related proteins with diverse biological roles Critical Reviews in Plant Sciences 17 575 692
115. B Liu H Bian J Bao 2010 Plant lectins: potential antineoplastic drugs from bench to clinic Cancer Letters 287 1 12 1:CAS:528:DC%2BD1MXhsFyntb3P 19487073 10.1016/j.canlet.2009.05.013
116. EG de Mejia VI Prisecaru 2005 Lectins as bioactive plant proteins: a potential in cancer treatment Critical Reviews in Food Science and Nutrition 45 425 445 16183566 10.1080/10408390591034445 1:CAS:528:DC%2BD2MXhtV2gsr%2FK (Pubitemid 43203787)
117. IF Pryme S Bardocz A Pusztail SWB Ewen 2006 Suppression of growth of tumour cell lines in vitro and tumours in vivo by mistletoe lectins Histology and Histopathology 21 285 299 1:CAS:528:DC%2BD28Xpt1Sqtw%3D%3D 16372250
118. P Lin TB Ng 2008 Preparation and biological properties of a melibiose binding lectin from Bauhinia variegate seeds Journal of Agricultural and Food Chemistry 56 10481 10486 1:CAS:528:DC%2BD1cXht1OlsLnF 18942841 10.1021/jf8016332
119. A Sharma TB Ng JH Wong P Lin 2009 Purification and characterization of a lectin from Phaseolus vulgaris cv. (Anasazi beans) Journal of Biomedicine & Biotechnology 2009 929568
120. J Chen B Liu N Ji J Zhou H Bian C Li, et al. 2009 A novel sialic acid-specific lectin from Phaseolus coccineus seeds with potent antineoplastic and antifungal activities Phytomedicine 16 352 360 1:CAS:528: DC%2BD1MXmt1Crtrg%3D 18757189 10.1016/j.phymed.2008.07.003
121. B Liu M Min JK Bao 2009 Induction of apoptosis by concanavalin A and its molecular mechanisms in cancer cells Autophagy 5 432 433 19202354 10.4161/auto.5.3.7924
122. SK Bhutia SK Mallick TK Maiti 2009 In vitro immunostimulatory properties of Arbus lectins derived peptides in tumor bearing mice Phytochemistry 16 776 782 1:CAS:528:DC%2BD1MXptVKrtbk%3D
123. D Ghosh TK Maiti 2007 Effects of native and heat-denatured Abrus agglutinin on tumor-associated macrophages in Dalton's lymphoma mice Immunobiology 212 667 673 1:CAS:528:DC%2BD2sXhtlSitrbJ 17869644 10.1016/j.imbio.2007.05.005 (Pubitemid 47377719)
124. LY Khil W Kim S Lyu WB Park JW Yoon HS Jun 2007 Mechanisms involved in Korean mistletoe lectin-induced apoptosis of cancer cells World Journal of Gastroenterology 13 2811 2818 1:CAS:528:DC%2BD2sXot1antr0%3D 17569116
125. YH Ma WZ Cheng F Gong AL Ma QW Yu JY Zhang, et al. 2008 Active Chinese mistletoe lectin-55 enhances colon cancer surveillance through regulating innate and adaptive immune responses World Journal of Gastroenterology 14 5274 5281 1:CAS:528:DC%2BD1MXhvFersrg%3D 18785279 10.3748/wjg.14.5274
126. P Monira Y Koyoma R Fukutomi K Yasui M Isemura H Yokogoshi 2009 Effects of Japanese mistletoe lectin on cytokine gene expression in human colonic carcinoma cells and in the mouse intestine Biomedical Research 30 303 309 1:CAS:528:DC%2BD1MXhsVSku7zM 19887727 10.2220/biomedres.30.303
127. SY Lyu WB Park 2009 Mistletoe lectin modulates intestinal epithelial cell-derived cytokines and B cell IgA secretion Archives of Pharmacal Research 32 443 451 1:CAS:528:DC%2BD1MXktFWlsbs%3D 19387590 10.1007/s12272-009-1319-6
128. G Seifert P Jesse A Laengler T Reindl M Luth S Lobitz, et al. 2008 Molecular mechanisms of mistletoe plant extract-induced apoptosis in acute lymphoblastic leukemia in vivo and in vitro Cancer Letters 264 218 228 1:CAS:528:DC%2BD1cXlslSisbg%3D 18314258 10.1016/j.canlet.2008.01.036
129. V Lavaster S Chiasson H Cavalli D Girard 2005 Viscum album agglutinin-I (VAA-I) induces apoptosis and degradation of cytoskeletal protein in human leukemia PLB-985 and X-CGD cells via caspases: Lamin B1 is a novel target of VAA-I Leukemia Research 29 1443 1453 10.1016/j.leukres.2005.05.014 1:CAS:528:DC%2BD2MXhtFOmsLfO (Pubitemid 41562247)
130. V Lavastre F Binet E Moisan S Chaisson D Girard 2007 Viscum album agglutinin-I induces degradation of cytoskeletal proteins in leukemia PLB-985 cells differentiated toward neutrophils: cleavage of non-muscle myosin heavy chain-IIA by caspases British Journal Haematology 138 545 554 1:CAS:528:DC%2BD2sXhtVehs7zM 10.1111/j.1365-2141.2007.06692.x (Pubitemid 47063040)
131. E Kovacs S Link U Toffol-Schmidt 2008 Comparison of Viscum album QuFrF extract with vincristine in an in vitro model of human B cell lymphoma WSU-1 Arzneimittelforschung 58 592 597 1:CAS:528:DC%2BD1MXhsVelsg%3D%3D 19137911
132. A Thies P Dautel A Meyer U Pfuller U Schumacher 2008 Low-dose mistletoe lectin-I reduces melanoma growth and spread in a scid mouse xenograft model British Journal of Cancer 98 106 112 1:CAS:528:DC%2BD1cXisF2qsQ%3D%3D 18026191 10.1038/sj.bjc.6604106
133. B Liu B Zhang M Min H Bian L Chen Q Liu, et al. 2009 Induction of apoptosis by Polygonatum odoratum lectin and its molecular mechanisms in murine fibrosarcoma L929 cells Biochimica et Biophysica Acta 1790 840 844 1:CAS:528:DC%2BD1MXotFyrsrs%3D 19414060
134. H Peng H Lv Y Wang Y Liu C Li L Meng, et al. 2009 Clematis Montana lectin, a novel mannose-binding lectin from traditional Chinese medicine with antiviral and apoptosis-inducing activities Peptides 30 1805 1815 1:CAS:528:DC%2BD1MXhtFyqt77M 19577602 10.1016/j.peptides.2009.06.027
135. Z Liu B Liu ZT Zhang TT Zhou HJ Bian MW Min, et al. 2008 A mannose-binding lectin from Sophora flavescens induces apoptosis in HeLa cells Phytomedicine 15 867 875 1:CAS:528:DC%2BD1cXhsVKmtrvP 18434118 10.1016/j.phymed.2008.02.025
136. C Freudlsperger A Thies U Pfuller U Schumacher 2007 The proteasome inhibitor bortezomib augments anti-proliferative effects pf mistletoe lectin-I and the PPAR-γ agonist rosiglitazone in human melanoma cells Anticancer Research 27 207 214 1:CAS:528:DC%2BD2sXjs1Wns7c%3D 17352234
137. L Sabova M Pilatova K Szilagyi R Sabo J Mojzis 2010 Cytotoxic effect of mistletoe (Viscum album L.) extract on Jurkat cells and its interaction with doxorubicin Phytotherapy Research 24 365 368 1:CAS:528:DC%2BC3cXktlyksr8%3D 19610041 10.1002/ptr.2947
138. B Hernandez-Ledesma CC Hsieh BO de Lumen 2009 Lunasin, a novel seed peptide for cancer prevention Peptides 30 426 430 1:CAS:528: DC%2BD1MXosVWisw%3D%3D 19056440 10.1016/j.peptides.2008.11.002
139. AF Galvez BO de Lumen 1999 A soybean cDNA encoding a chromatin-binding peptide inhibits mitosis of mammalian cells Nature Biotechnology 17 495 500 1:CAS:528:DyaK1MXivFaju7k%3D 10331812 10.1038/8676 (Pubitemid 29217905)
140. AF Galvez N Chen J Macasieb BO de Lumen 2001 Chemopreventive property of a soybean peptide (luasin) that binds to deacetylated histones and inhibits acetylation Cancer Research 61 7473 7478 1:CAS:528:DC%2BD3MXnvFShsLs%3D 11606382
141. EA Hsieh CM Chai BO de Lumen RA Neese MK Hellerstein 2004 Dynamics of keratinocytes in vivo using (H2O)-H2 labeling: a sensitive marker of epidermal proliferation rate The Journal of Investigative Dermatology 123 530 536 1:CAS:528:DC%2BD2cXnsValtL0%3D 15304093 10.1111/j.0022-202X.2004.23303.x (Pubitemid 39095624)
142. HJ Jeong JH Park Y Lam BO de Lumen 2003 Characterization of lunasin isolated from soybean Journal of Agricultural and Food Chemistry 51 7901 7906 1:CAS:528:DC%2BD3sXptlKjs7g%3D 14690371 10.1021/jf034460y
143. HJ Jeong Y Lam BO de Lumen 2002 Barley lunasin suppresses ras-induced colony formation and inhibits core histone acetylation in mammalian cells Journal of Agricultural and Food Chemistry 50 5903 5908 1:CAS:528: DC%2BD38XntVahsbo%3D 12358457 10.1021/jf0256945 (Pubitemid 35155312)
144. HJ Jeong JB Jeong DS Kim JH Park JB Lee DH Kweon, et al. 2007 The cancer preventive peptide lunasin from wheat inhibits core histone acetylation Cancer Letters 255 42 48 1:CAS:528:DC%2BD2sXovFGmsL8%3D 17481808 10.1016/j.canlet.2007. 03.022 (Pubitemid 47212604)
145. JB Jeong HJ Jeong JH Park SH Lee JR Lee HK Lee, et al. 2007 Cancer-preventive peptide lunasin from Solanum nigrum L. inhibits acetylation of core histones H3 and H4 and phosphorylation of retinoblastoma protein (Rb) Journal of Agricultural and Food Chemistry 55 10707 10713 1:CAS:528: DC%2BD2sXhtlGnt77O 18038993 10.1021/jf072363p
146. HJ Jeong JR Lee JB Joeng JH Park YK Cheong BO de Lumen 2009 The cancer preventive seed peptide lunasin from rye is bioavailable and bioactive Nutrition and Cancer 61 680 686 1:CAS:528:DC%2BD1MXht12gsr%2FE 19838942 10.1080/01635580902850082
147. C Silva-Sanchez APB dela Rosa MF Leon-Galvan BO de Lumen A de Leon-Rodriguez EG de Mejia 2008 Bioactive peptides from amaranth (Amaranthus hypochondriacus) seed Journal of Agricultural and Food Chemistry 56 1233 1240 1:CAS:528:DC%2BD1cXptlyrtQ%3D%3D 18211015 10.1021/jf072911z (Pubitemid 351364052)
148. JB Jeong BO de Lumen HJ Jeong 2010 Lunasin peptide purified from Solanum nigrum L. protects DNA from oxidative damage by suppressing the generation of hydroxyl radical via blocking fenton reaction Cancer Letters 293 58 64 1:CAS:528:DC%2BC3cXlsVyitrY%3D 20083341 10.1016/j.canlet.2009.12.019
149. Y Lam A Galvez BO de Lumen 2003 Lunasin™ suppresses E1A-mediated transformation of mammalian cells but does not inhibit growth of immortalized and established cancer cell lines Nutrition and Cancer 47 88 94 1:CAS:528:DC%2BD2cXitlylt7o%3D 14769542 10.1207/s15327914nc470111
150. VP Dia W Wang VL Oh BO de Lumen EG de Mejia 2009 Isolation, purification and characterisation of lunasin from defatted soybean flour and in vitro evaluation of its anti-inflammatory activity Food Chemistry 114 108 115 1:CAS:528:DC%2BD1MXmvVeqsw%3D%3D 10.1016/j.foodchem.2008.09.023
151. EG de Mejia VP Dia 2009 Lunasin and lunasin-like peptides inhibit inflammation through suppression of NF-kappa B pathway in the macrophage Peptides 30 2388 2398 19682518 10.1016/j.peptides.2009.08.005 1:CAS:528:DC%2BD1MXhsVKntLvJ
152. B Hernandez-Ledesma CC Hsieh BO de Lumen 2009 Antioxidant and anti-inflammatory properties of cancer preventive peptide lunasin in RAW 264.7 macrophages Biochemical and Biophysical Research Communications 390 803 808 1:CAS:528:DC%2BD1MXhsVKgur7N 19836349 10.1016/j.bbrc.2009.10.053
153. EG de Mejia WY Wang VP Dia 2010 Lunasin, with an arginine-glycine- aspartic acid motif, causes apoptosis to L1210 leukemia cells by activation of caspase-3 Molecular Nutrition & Food Research 54 406 414 10.1002/mnfr.200900073 1:CAS:528:DC%2BC3cXjtFKhs7o%3D
154. VP Dia EG de Mejia 2010 Lunasin promotes apoptosis in human colon cancer cells by mitochondrial pathway activation and induction of nuclear clusterin expression Cancer Letters 295 44 53 1:CAS:528:DC%2BC3cXntVSmsb8%3D 20206442 10.1016/j.canlet.2010.02.010
155. CC Hsieh B Hernandez-Ledesma HJ Jeong JH Park BO de Lumen 2010 Complementary roles in cancer prevention: protease inhibitor makes the cancer preventive peptide lunasin bioavailable PLoS ONE 5 e8890 20126654 10.1371/journal.pone.0008890 1:CAS:528:DC%2BC3cXhtlGks78%3D
156. VP Dia S Torres BO de Lumen JW Erdman EG de Mejia 2009 Presence of lunasin in plasma of men after soy protein consumption Journal of Agricultural and Food Chemistry 57 1260 1266 1:CAS:528:DC%2BD1MXhtVejsr0%3D 19199603 10.1021/jf803303k
157. CL Yeh MH Pai CC Li YL Tsai SL Yeh 2010 Effect of arginine on angiogenesis induced by human colon cancer: in vitro and in vivo studies The Journal of Nutritional Biochemistry 21 539 543 10.1016/j.jnutbio.2009.03.005 1:CAS:528:DC%2BC3cXmtFCht7g%3D
158. CL Yeh CS Hsu SC Chen YC Hou WC Chiu SL Yeh 2007 Effect of arginine on cellular adhesion molecule expression and leukocyte transmigration in endothelial cells stimulated by biological fluid from surgical patients Shock 28 39 44 1:CAS:528:DC%2BD2sXotV2gtL4%3D 17483743 10.1097/shk.0b013e31802f0190 (Pubitemid 46956461)
159. SY Chou CS Hsu MY Hsu SJ Liang CL Yeh SL Yeh 2009 Effects of different arginine concentrations on angiogenic protein production induced by HeLa cells Nutrition 26 818 822 10.1016/j.nut.2009.08.004 10.1016/j.nut.2009.08.004 1:CAS:528:DC%2BC3cXnvVOru78%3D
160. ML Rose J Madren H Bunzendahl RG Thruman 1999 Dietary glycine inhibits the growth of B16 melanoma tumors in mice Carcinogenesis 20 793 798 1:CAS:528:DyaK1MXjtVantb4%3D 10334195 10.1093/carcin/20.5.793
161. ML Rose RC Cattley C Dunn V Wong X Li RG Thurman 1999 Dietary glycine prevents the development of liver tumors caused by the peroxisome proliferator WY-14, 643 Carcinogenesis 20 2075 2081 1:CAS:528:DyaK1MXns1Kjsbo%3D 10545408 10.1093/carcin/20.11.2075 (Pubitemid 29535307)
162. J Yoshiji R Noguchi K Kaji Y Ikenaka Y Shirai T Namisaki, et al. 2010 Attenuation of insulin-resistance-based hepatocarcinogenesis and angiogenesis by combined treatment with branched-chain amino acids and angiotensin-converting enzyme inhibitor in obese diabetic rats Journal of Gastroenterology 45 443 450 1:CAS:528:DC%2BC3cXksFCns7o%3D 19941011 10.1007/s00535-009-0158-z
163. H Kobayashi R Yoshida Y Kanada Y Fukuda T Yagyu K Inagaki, et al. 2005 Suppression of lipopolysaccharide-induced cytokine production of gingival fibroblasts by a soybean, Kunitz trypsin inhibitor Journal of Periodontal Research 40 461 468 1:CAS:528:DC%2BD28XitFGqsQ%3D%3D 16302924 10.1111/j.1600-0765.2005.00824.x (Pubitemid 41673750)
164. H Kobayashi R Yoshida Y Kanada Y Fukuda T Yagyu K Inagaki, et al. 2005 A soybean Kunitz trypsin inhibitor reduces tumor necrosis factor-α production in ultraviolet-exposed primary human keratinocytes Experimental Dermatology 14 765 774 1:CAS:528:DC%2BD2MXhtF2ntrrL 16176285 10.1111/j.0906-6705.2005.0266p.x
165. HY Lei CP Chang 2007 Induction of autophagy by concanavalin A and its application in anti-tumor therapy Autophagy 3 402 404 1:CAS:528: DC%2BD2sXhtVGrtb7I 17471013
166. B Liu Y Cheng HJ Bian JK Bao 2009 Molecular mechanisms of Polygonatum cyrtonema lectin-induced apoptosis and autophagy in cancer cells Autophagy 5 253 255 1:CAS:528:DC%2BD1MXovFeiurs%3D 19139634 10.4161/auto.5.2.7561
167. B Liu Y Cheng B Zhang HJ Bian JK Bao 2009 Polygonatum cyrtonema lectin induces apoptosis and autophagy in human melanoma A375 cells through a mitochondria-mediated ROS-p38-p53 pathway Cancer Letters 275 54 60 1:CAS:528:DC%2BD1MXhtVeiurY%3D 19010591 10.1016/j.canlet.2008.09.042
168. CP Chang HY Lei 2008 Autophagy induction in T cell-independent acute hepatitis induced by concanavalin A in scid/nod mice International Journal of Immunopathology and Pharmacology 21 817 826 1:CAS:528:DC%2BD1MXivFSqsrk%3D 19144267
169. M Augustin PR Bock J Hanisch M Karasmann B Schneider 2005 Safety and efficacy of the long term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract-results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland Arzneimittelforschung 55 38 49 1:CAS:528:DC%2BD2MXhtlCnu7w%3D 15727163
170. M Mabed L El-Helw S Shamaa 2004 Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma British Journal of Cancer 90 65 69 1:CAS:528:DC%2BD2cXhtFKnsg%3D%3D 14710208 10.1038/sj.bjc.6601463 (Pubitemid 38174940)
171. P Schoffski S Riggert P Fumoleau M Campone O Bolte S Marreaud D Lacombe, et al. 2004 Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: a study of the European Organization for Research and Treatment of Cancer New Drug Development Group Annals of Oncology 15 1816 1824 1:STN:280:DC%2BD2crotVGhsg%3D%3D 15550588 10.1093/annonc/mdh469 (Pubitemid 40017162)
172. SB Malkowicz WG McKenna DJ Vaughn XS Wan KJ Propert K Rockwell, et al. 2001 Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia The Prostate 48 16 28 1:CAS:528:DC%2BD3MXltVOgsr4%3D 11391683 10.1002/pros.1077 (Pubitemid 32545073)
173. WB Armstrong AR Kennedy XS Wan J Atiba E McLaren FL Meyskens 2000 Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia Cancer Epidemiology, Biomarkers & Prevention 9 43 47 1:CAS:528:DC%2BD3cXptVOmtQ%3D%3D
174. WB Armstrong AR Kennedy XS Wan TH Taylor QA Nguyen J Jensen W Thomson, et al. 2000 Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial Clinical Cancer Research 6 4684 4691 1:CAS:528:DC%2BD3MXotlemsA%3D%3D 11156220